CVE-2023-21564
Azure DevOps Server Cross-Site Scripting Vulnerability
CVE-2023-21564 is a high vulnerability (CVSS 7.1) in Microsoft Azure Devops Server, published February 14, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.89%, the 59th percentile. No source names a fixed version.
- Severity
- 7.1 HighCVSS 3.1, CVE List
- Exploit chance
- 0.89%EPSS, 59th percentile
- Exploitation
- None knownNot on CISA’s or ENISA’s lists
- Fixed in
- No fix listedNo source names one
Description
Azure DevOps Server Cross-Site Scripting Vulnerability
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- Low
- Availability
- None
Exploit likelihood
Affected products
What each source reports
CVE List Score used 7.1
Azure DevOps Server Cross-Site Scripting Vulnerability
Azure DevOps Server Cross-Site Scripting Vulnerability
- Record
CVE-2023-21564- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N/E:U/RL:O/RC:C - Weakness
- CWE-79
- Updated
- 2026-11-02
EUVDEUVD-2023-25731 7.1
Azure DevOps Server Cross-Site Scripting Vulnerability
- Record
EUVD-2023-25731- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N/E:U/RL:O/RC:C - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-fvm6-3mw8-9cq2 7.1
Azure DevOps Server Cross-Site Scripting Vulnerability
Azure DevOps Server Cross-Site Scripting Vulnerability
- Record
GHSA-fvm6-3mw8-9cq2- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
NVD 7.1
Azure DevOps Server Cross-Site Scripting Vulnerability
- Record
CVE-2023-21564- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.